© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Aztreonam Pure Powder stands out as a synthetic monobactam antibiotic raw material, consistently used across the pharmaceutical sector for its ability to fight Gram-negative bacterial infections. Known for its high purity and stability, it is widely selected as a fundamental starting material by companies developing intravenous or inhaled medicines. Found both in clinical laboratories and manufacturing plants, it displays as a white to off-white solid, usually in finely milled powder form, though sometimes showing as flakes, crystalline granules, or even small pearls, depending on the production process and storage environment.
The molecular formula for Aztreonam is C13H17N5O8S2, while its structure features a monocyclic beta-lactam ring, which differentiates it from other classes of antibiotics like penicillins and cephalosporins. The molecular weight clocks in at approximately 435.44 grams per mole, critical for accurate dosing and solution preparation. Its high aqueous solubility and specific structure enable it to maintain activity against a wide range of pathogens. A density of around 1.79 g/cm³ (measured at typical laboratory temperature and pressure) assists with storage and transport calculations, and reveals something of its robust solid-state characteristics.
Looking at Aztreonam Pure Powder, the typical solid is odorless, nearly tasteless, and comes in a fine granular crystalline form. Some suppliers produce it as larger flakes or sparkle-like pearls to reduce airborne dispersion. No matter the form, the material retains its inherent stability against light and moderate humidity, though direct contact with water or high moisture environments is avoided to prevent hydrolysis. Powders arrive in sealed, opaque containers—glass jars for laboratory use, multi-layered polymer bags inside rigid drums for bulk shipments. Handling practices treat it with the same caution reserved for potent antimicrobials, with clear guidance posted on safety data sheets regarding any dust generation and inhalation risks.
Aztreonam Pure Powder specification covers purity, usually not less than 98% by HPLC, with strict maxima set for related substances and residual solvents. Water content typically stays below 2.5%, and heavy metal contaminants fall far below established pharmacopeial thresholds. Aztreonam features the Harmonized System (HS) Code 29419090, grouped with other antibiotics. Compliance with ICH Q7 for active pharmaceutical ingredients, along with regular batch analysis certificates, keeps manufacturing well within regulatory requirements. This information supports global trade and meets customs documentation needs, making sure the flow of raw material to manufacturers and research organizations continues without unnecessary hold-ups.
Aztreonam Pure Powder retains excellent reputation for targeted antibacterial action, but handling the raw product means applying respect for its hazardous nature. Dust produced during transfer or weighing has potential to irritate eyes, nose, and skin, raising the need for goggles, gloves, and effective dust extraction or fume hoods. Inhalation of airborne particles or accidental ingestion requires immediate medical attention. The material isn’t classified as explosive or flammable, though it’s toxic if misused or handled without training. Safe disposal protocols and spill response procedures always apply; residual powder gets collected with care and handled according to local chemical waste rules. Keeping emergency first aid kits and eye-wash stations nearby in any facility handling Aztreonam solves most rare but possible accidents.
Stability testing shows Aztreonam remains stable at room temperature for reasonable processing times, but long-term storage calls for cool, dry, dark places—typically between 2°C and 8°C. Rapid decomposition happens only in strong acids, bases, or prolonged exposure to direct sunlight, so segregation from such chemicals makes good sense. The powder does not present a risk of violent reaction with glass, plastics, or common metals under ordinary working conditions, which helps reduce facility maintenance risks. Dissolution in water creates a clear, slightly acidic solution, favored for pharmaceutical formulation or assay. Stock solutions should be used within specified time frames to maintain maximum antimicrobial activity.
Shortages or impurities in Aztreonam disrupt critical care options for patients with severe infections where alternative antibiotics fail, so transparency in source, quality, and safe handling is essential. Only reliable, high-purity Aztreonam supports the development of sterile injectables meeting international standards. Maintaining consistent material specs results in efficient manufacturing, better therapeutic outcomes, and public trust in pharmaceutical treatments. Detailed records and certificates of analysis become non-negotiable elements of every shipment, ensuring traceability and immediate response to any supply chain anomaly. Training workers in safe chemical handling, along with investment in proper ventilation and waste disposal, stands out as a practical solution for keeping risk low in labs and factories. Encouraging upgrades to storage and packaging further reduces incidents linked to accidental moisture exposure or cross-contamination with other raw materials.
Knowing the source and journey of every kilogram of Aztreonam underpins responsible medicine production and safeguards patient outcomes. Trust grows with suppliers who publish full product specs, audit results, and real-time batch information, not just for compliance but for peace of mind throughout the healthcare chain. Buyers remain vigilant for counterfeit or substandard powder, so a robust auditing and certification ecosystem grows in importance. As discussions around rare drug shortages and antimicrobial stewardship intensify, pharmacists, manufacturers, and regulators sit at the same table, recognizing that real lives depend on their diligence, and every detail in Aztreonam Pure Powder’s journey represents a link in the chain to safer healthcare everywhere.
